Indeed, brevilin A at sub-IC50 concentrations abolished the activation of HSCs that were cultured in CRC cell conditioned medium (Fig. 4D, E), or in the presence of VEGFA (Fig. 4F). This evidence concerns the gene VEGFA and colorectal carcinoma.